LLY
Eli Lilly and Company
Eli Lilly and Company historical holders
total: 12
Lountzis Asset Management Eli Lilly and Company transactions over time
- Total transactions:
- 2
- New positions:
- 1
- Added:
- 1
- Held since:
- 2025 Q1
- Held for:
- 5 quarters
- Latest activity:
- 2026 Q1
Paul Lountzis has been an institutional investor in Eli Lilly and Company (LLY) since 2025 Q1. According to 2026 Q1 report, Paul Lountzis holds 312 shares with a market value of roughly $286.97K representing 0.11% of their equity portfolio. The fund/company first acquired LLY in 2025 Q1, initially purchasing 292 shares. Since the initial investment, Lountzis Asset Management has made 1 more transaction in this position.
Does Paul Lountzis still hold LLY?
Yes, Paul Lountzis continues to hold Eli Lilly and Company (LLY). According to their 2026 Q1 report, they maintain a position of 312 shares valued at approximately $286.97K, representing 0.11% of their equity portfolio.
When did Paul Lountzis first invest in LLY?
Paul Lountzis first invested in Eli Lilly and Company (LLY) in 2025 Q1 at the reported quarter-end price of $877.29 per share, acquiring 292 shares in their initial purchase.
What is Paul Lountzis's average cost basis for LLY?
Based on historical transaction data, Paul Lountzis's estimated cost basis for Eli Lilly and Company (LLY) is approximately $880.01 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $880.01
LLY transactions history by Lountzis Asset Management
2 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
0.11%
|
312
|
$919.77
|
$286,968
|
+6.85% (+20)
|
+0.01%
|
|
2025 Q1
|
0.10%
|
292
|
$877.29
|
$256,169
|
new
|
+0.1%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.